Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells.
Rinaldi A, Dumas F, Duskey JT, Imbriano C, Belluti S, Roy C, Ottonelli I, Vandelli MA, Ruozi B, Garcion E, Tosi G, Boury F.
Rinaldi A, et al. Among authors: imbriano c.
Int J Pharm. 2024 Apr 10;654:123994. doi: 10.1016/j.ijpharm.2024.123994. Epub 2024 Mar 12.
Int J Pharm. 2024.
PMID: 38484859